Age group (years) | Males | Females | ||||
---|---|---|---|---|---|---|
Incidence (95 % CI)a | Expected cases | SIR (95 % CI) | Incidence (95 % CI)a | Expected cases | SIR (95 % CI) | |
0–4 | 0.8 (0.5–1.1) | 114 | 0.38 (0.27–0.51) | 0.3 (0.2–0.6) | 41 | 0.91 (0.64–1.24) |
5–9 | 0.8 (0.5–1.1) | 121 | 0.22 (0.14–0.32) | 0.6 (0.4–1.0) | 86 | 0.21 (0.12–0.33) |
10–14 | 0.5 (0.3–0.8) | 77 | 0.53 (0.38–0.72) | 0.8 (0.5–1.1) | 117 | 0.33 (0.23–0.45) |
15–19 | 1.6 (1.3–2.1) | 268 | 0.48 (0.40–0.57) | 1.3 (1.0–1.7) | 207 | 0.39 (0.31–0.49) |
20–24 | 2.7 (2.2–3.3) | 506 | 0.70 (0.63–0.78) | 1.8 (1.4–2.3) | 319 | 0.56 (0.49–0.65) |
25–29 | 4.0 (3.4–4.7) | 834 | 0.82 (0.76–0.88) | 3.0 (2.5–3.6) | 602 | 0.67 (0.61–0.74) |
30–34 | 4.8 (4.1–5.6) | 1152 | 1.20 (1.14–1.27) | 4.0 (3.4–4.7) | 933 | 0.78 (0.72–0.84) |
35–39 | 7.4 (6.5–8.3) | 1635 | 1.33 (1.28–1.39) | 5.0 (4.3–5.7) | 1080 | 0.97 (0.91–1.03) |
40–44 | 10.4 (9.4–11.5) | 2065 | 1.47 (1.42–1.52) | 6.8 (6.0–7.7) | 1327 | 1.09 (1.04–1.15) |
45–49 | 13.7 (12.5–15.0) | 2644 | 1.79 (1.74–1.84) | 8.7 (7.9–9.8) | 1666 | 1.34 (1.29–1.40) |
50–54 | 18.5 (17.0–20.1) | 4078 | 2.05 (2.00–2.09) | 10.8 (9.7–12.0) | 2393 | 1.66 (1.60–1.71) |
55–59 | 23.6 (21.9–25.5) | 5839 | 2.22 (2.18–2.26) | 16.3 (14.8–17.8) | 4122 | 1.37 (1.33–1.41) |
60–64 | 32.1 (29.8–34.7) | 6538 | 2.14 (2.10–2.18) | 21.2 (19.4–23.3) | 4567 | 1.45 (1.41–1.48) |
65–69 | 49.8 (46.4–53.4) | 8895 | 1.80 (1.77–1.83) | 33.7 (31.1–36.6) | 6616 | 1.24 (1.22–1.27) |
70–74 | 80.6 (75.8–85.8) | 12,225 | 1.45 (1.43–4.70) | 50.1 (46.6–53.9) | 8982 | 1.04 (1.02–1.06) |
75–79 | 127.5 (120.6–134.9) | 14,272 | 1.07 (1.05–1.09) | 75.8 (71.1–80.8) | 11,345 | 0.87 (0.85–0.89) |
80–84 | 216.1 (204.7–228.1) | 13,356 | 0.68 (0.67–0.70) | 117.5 (110.8–124.7) | 12,872 | 0.59 (0.58–0.60) |
≥85 | 447.3 (524.7–570.0) | 18,168 | 0.25 (0.24–0.26) | 318.7 (305.3–332.8) | 33,654 | 0.14 (0.14–0.15) |
Total | 26.1 (22.5–30.0) | 92,784 | 1.19 (1.18–1.20) | 17.0 (14.9–19.2) | 90,930 | 0.68 (0.68–0.69) |